newsfilter
← Latest News
GlobeNewswire·

Akouos Reports First Quarter 2021 Financial Results and Provides Business Updates

- Leadership team expanded with appointment of Kathy Reape, M.D. as chief development officer - AK-OTOF granted both Orphan Drug Designation and Rare Pediatric Disease Designation by FDA and is on track for planned IND submission in first half of 20